DK0514711T3 - Aspirintablet med pufret matrix - Google Patents

Aspirintablet med pufret matrix

Info

Publication number
DK0514711T3
DK0514711T3 DK92107674.1T DK92107674T DK0514711T3 DK 0514711 T3 DK0514711 T3 DK 0514711T3 DK 92107674 T DK92107674 T DK 92107674T DK 0514711 T3 DK0514711 T3 DK 0514711T3
Authority
DK
Denmark
Prior art keywords
tablet
aspirin tablet
aspirin
buffered
matrix material
Prior art date
Application number
DK92107674.1T
Other languages
Danish (da)
English (en)
Inventor
Cynthia M Blase
Garnet E Peck
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0514711T3 publication Critical patent/DK0514711T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92107674.1T 1991-05-20 1992-05-07 Aspirintablet med pufret matrix DK0514711T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70250491A 1991-05-20 1991-05-20

Publications (1)

Publication Number Publication Date
DK0514711T3 true DK0514711T3 (da) 1996-08-12

Family

ID=24821482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92107674.1T DK0514711T3 (da) 1991-05-20 1992-05-07 Aspirintablet med pufret matrix

Country Status (11)

Country Link
US (1) US5576024A (fr)
EP (1) EP0514711B1 (fr)
JP (1) JP3150763B2 (fr)
KR (1) KR100225017B1 (fr)
AT (1) ATE135222T1 (fr)
AU (1) AU636538B2 (fr)
CA (1) CA2067975C (fr)
DE (1) DE69208934T2 (fr)
DK (1) DK0514711T3 (fr)
ES (1) ES2084867T3 (fr)
GR (1) GR3019826T3 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238697B1 (en) 1998-12-21 2001-05-29 Pharmalogix, Inc. Methods and formulations for making bupropion hydrochloride tablets using direct compression
US20020022058A1 (en) * 2000-07-08 2002-02-21 Lovercheck Dale R. Unit dose of material in system and method
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
LU85943A1 (fr) * 1985-06-12 1987-01-13 Galephar Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
US4869984A (en) * 1988-12-21 1989-09-26 Eastman Kodak Company Electrophotographic elements containing certain naphthoquinone derivatives as electron-transport agents
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith

Also Published As

Publication number Publication date
AU1639092A (en) 1992-12-10
KR920021136A (ko) 1992-12-18
ES2084867T3 (es) 1996-05-16
EP0514711A1 (fr) 1992-11-25
CA2067975A1 (fr) 1992-11-21
DE69208934T2 (de) 1996-07-25
CA2067975C (fr) 2003-01-14
AU636538B2 (en) 1993-04-29
JP3150763B2 (ja) 2001-03-26
US5576024A (en) 1996-11-19
KR100225017B1 (ko) 1999-10-15
DE69208934D1 (de) 1996-04-18
EP0514711B1 (fr) 1996-03-13
ATE135222T1 (de) 1996-03-15
JPH05170652A (ja) 1993-07-09
GR3019826T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
DE69221844D1 (de) LCD-Anzeige mit rückseitigem mikrotexturiertem Reflektor sowie Verfahren zu seiner Herstellung
DE69401325D1 (de) Superabsorbierendes Polymer mit verbesserten Absorbiereigenschaften und Absorption unter Druck
AU8676791A (en) Clip and osteosynthesis plate with dynamic compression and self-retention
NO900990D0 (no) Systemer for lagring og utlevering av gass.
IT9067586A0 (it) Miscela polimerica amidacea particolarmente per la produzione di film e simili e procedimento per la sua produzione.
DE69112698D1 (de) Anzeigeeinrichtung von höher Qualität mit aktiver Matrix.
TR199700845T1 (xx) Aerojel'lerin tar�mda kullan�lmas�.
GR3024244T3 (en) Transmucosal drug delivery device.
AU3220593A (en) Soluble mhc molecules and their uses
DE69106154D1 (de) Verzögerte Freisetzung mit hoch- und niedrigviskoser HPMC.
AU3419593A (en) Medicine reminder and storage device
DE69233491D1 (de) Pharmazeutische Zusammensetzung enthaltend S-Nitrosolipoproteine und deren Verwendung
DE68912482D1 (de) Dünnfilm-Transistoren, ihre Verfahren zur Herstellung und Anzeigeeinrichtung, die mit solchen Transistoren hergestellt sind.
EP0475434A3 (en) Polymer composition and its use
DE69222659D1 (de) Reproduktionsmethode und Reproduktionsapparat mit verbesserter Anzeige
IL90278A0 (en) Tablet coated with polymeric film
DE59107827D1 (de) Teilchenförmiges Pfropfpolymerisat mit verbesserter Haftung zwischen Pfropfgrundlage und Pfropfhülle
DE69020173D1 (de) Aktives Matrix-Substrat und Anzeigevorrichtung mit dieser aktiven Matrix.
EP0352061A3 (en) Metal material with film passivated by fluorination and apparatus composed of the metal material
DE69433614D1 (de) Anzeigevorrichtung mit aktiver matrix
DE69219403D1 (de) Plattenverstärkendes Folienmaterial sowie dasselbe gebrauchende äussere Fahrzeugpaneelstruktur
IT8553578V0 (it) Sopporto a treppiede particolarmente per macchine cinematografiche da ripresa e simili
CA2106312A1 (fr) Anesthesie percutanee
DK0514711T3 (da) Aspirintablet med pufret matrix
DE68912881D1 (de) Kontinuierliche Säugetier-Zellinien mit monozyt/makrophagen Eigenschaften und deren Einrichtung in vitro.